Stock markets rallied after Donald Trump’s victory in the US presidential election, pushing dozens of names into overvalued ...
Congress may approve stronger pharmacy benefit manager rules after years of debate, in part to cover the cost of Medicare ...
Maternal RSV vaccination enhances antibody transfer to newborns, with optimal transfer efficiency observed when given at ...
A new California law will require a human to sign off on decisions by AI-generated algorithms, while another law requires ...
Symptom screening improved symptom scores among children with cancer compared with usual care, two randomized trials showed.
Cigna no longer pays commissions for enrollments into nearly ... a field marketing organization. UnitedHealth Group, which ...
Benzinga on MSN2d
Cigna Abandons Humana Merger Talks, Instead Eyes Targeted Acquisitions and Aggressive Share BuybacksCigna Group announced Monday it is not pursuing a merger with Humana. The announcement squashes speculation fueled by Donald ...
"The Cigna Group remains committed to its established M&A criteria and would only consider acquisitions that are ...
A slew of rules is sitting at the White House awaiting the Biden administration’s sign-off before the FDA can issue them.
In a report released yesterday, Erin Wright from Morgan Stanley maintained a Buy rating on Cigna (CI – Research Report), with a price ...
Analyst Steve Baxter of Wells Fargo maintained a Hold rating on Cigna (CI – Research Report), retaining the price target of $355.00.
On Monday, Cigna Group (CI) stock saw a modest uptick, ending the day at $343.06 which represents a slight increase of $23.29 or 7.28% from the prior close of $319.77. The stock opened at $344.94 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback